Allworth Financial LP Lucid Diagnostics Inc. Transaction History
Allworth Financial LP
- $17.3 Billion
- Q4 2024
A detailed history of Allworth Financial LP transactions in Lucid Diagnostics Inc. stock. As of the latest transaction made, Allworth Financial LP holds 110 shares of LUCD stock, worth $104. This represents 0.0% of its overall portfolio holdings.
Number of Shares
110
Previous 167
34.13%
Holding current value
$104
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding LUCD
# of Institutions
30Shares Held
3.09MCall Options Held
0Put Options Held
0-
Luminus Management LLC Houston, TX1.15MShares$1.1 Million0.56% of portfolio
-
Vanguard Group Inc Valley Forge, PA561KShares$532,8690.0% of portfolio
-
Sargent Investment Group, LLC542KShares$514,4250.07% of portfolio
-
Geode Capital Management, LLC Boston, MA214KShares$202,8630.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT126KShares$120,0430.01% of portfolio
About Lucid Diagnostics Inc.
- Ticker LUCD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 38,568,500
- Market Cap $36.6M
- Description
- Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarc...